| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Involvement of the biliary system in autoimmune pancreatitis: a follow-up study.
|
Clin Gastroenterol Hepatol
|
2003
|
2.13
|
|
2
|
Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
|
Clin Gastroenterol Hepatol
|
2006
|
2.05
|
|
3
|
Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography.
|
Eur J Radiol
|
2005
|
1.68
|
|
4
|
Efficacy and safety of low-pressured and short-time dilation in endoscopic papillary balloon dilation for bile duct stone removal.
|
J Gastroenterol Hepatol
|
2007
|
1.60
|
|
5
|
Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
|
Gastrointest Endosc
|
2013
|
1.58
|
|
6
|
Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin E.
|
Clin Gastroenterol Hepatol
|
2011
|
1.44
|
|
7
|
Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.
|
Gastrointest Endosc
|
2005
|
1.32
|
|
8
|
Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction.
|
Clin Gastroenterol Hepatol
|
2006
|
1.31
|
|
9
|
Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.
|
Am J Gastroenterol
|
2002
|
1.24
|
|
10
|
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.
|
J Viral Hepat
|
2014
|
1.23
|
|
11
|
Measurement of radial and axial forces of biliary self-expandable metallic stents.
|
Gastrointest Endosc
|
2009
|
1.22
|
|
12
|
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.
|
Cancer Chemother Pharmacol
|
2009
|
1.20
|
|
13
|
Pancreatic mass lesions associated with raised concentration of IgG4.
|
Am J Gastroenterol
|
2004
|
1.19
|
|
14
|
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
|
Clin Gastroenterol Hepatol
|
2005
|
1.18
|
|
15
|
Prevalence and sonographic detection of Chilaiditi's sign in cirrhotic patients without ascites.
|
AJR Am J Roentgenol
|
2006
|
1.15
|
|
16
|
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine.
|
Invest New Drugs
|
2010
|
1.08
|
|
17
|
Impact of S-1 on the survival of patients with advanced pancreatic cancer.
|
Pancreas
|
2010
|
1.06
|
|
18
|
Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1000 patients.
|
Clin Gastroenterol Hepatol
|
2007
|
1.05
|
|
19
|
Serum IgG4 concentrations in pancreatic and biliary diseases.
|
Clin Chim Acta
|
2006
|
1.05
|
|
20
|
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer.
|
Cancer Chemother Pharmacol
|
2013
|
1.04
|
|
21
|
Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction.
|
Dig Endosc
|
2012
|
1.01
|
|
22
|
New method of covered wallstents for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics.
|
Dig Endosc
|
2010
|
1.00
|
|
23
|
Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance.
|
Pancreas
|
2012
|
0.99
|
|
24
|
Preserved function of the Oddi sphincter after endoscopic papillary balloon dilation.
|
Hepatogastroenterology
|
2003
|
0.94
|
|
25
|
Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent.
|
Gastrointest Endosc
|
2012
|
0.93
|
|
26
|
Risk factors for pancreatitis following transpapillary self-expandable metal stent placement.
|
Surg Endosc
|
2011
|
0.93
|
|
27
|
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
|
Cancer Chemother Pharmacol
|
2010
|
0.92
|
|
28
|
Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study.
|
Gastrointest Endosc
|
2012
|
0.91
|
|
29
|
Management of occluded uncovered metallic stents in patients with malignant distal biliary obstructions using covered metallic stents.
|
J Clin Gastroenterol
|
2008
|
0.91
|
|
30
|
A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer.
|
Oncology
|
2009
|
0.91
|
|
31
|
Incidental pancreatic cysts found by magnetic resonance imaging and their relationship with pancreatic cancer.
|
Pancreas
|
2012
|
0.88
|
|
32
|
Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis.
|
J Gastroenterol
|
2012
|
0.87
|
|
33
|
Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self-expandable metallic stents for palliation.
|
Dig Endosc
|
2011
|
0.87
|
|
34
|
High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitis.
|
Pancreas
|
2013
|
0.87
|
|
35
|
Successful treatment for groove pancreatitis by endoscopic drainage via the minor papilla.
|
Gastrointest Endosc
|
2005
|
0.87
|
|
36
|
Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
|
J Clin Gastroenterol
|
2016
|
0.85
|
|
37
|
One- and two-step self-expandable metal stent placement for distal malignant biliary obstruction: a propensity analysis.
|
J Gastroenterol
|
2012
|
0.85
|
|
38
|
Histological analysis of the papilla after endoscopic papillary balloon dilation.
|
Hepatogastroenterology
|
2003
|
0.85
|
|
39
|
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
|
ScientificWorldJournal
|
2012
|
0.85
|
|
40
|
Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
|
Am J Hematol
|
2008
|
0.84
|
|
41
|
Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstruction.
|
Dig Endosc
|
2014
|
0.84
|
|
42
|
Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer.
|
Gastrointest Endosc
|
2011
|
0.83
|
|
43
|
Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases.
|
Surg Endosc
|
2011
|
0.83
|
|
44
|
Incidence of malignancies in patients with IgG4-related disease.
|
Intern Med
|
2014
|
0.81
|
|
45
|
Outcomes after clearance of pancreatic stones with or without pancreatic stenting.
|
J Gastroenterol
|
2007
|
0.81
|
|
46
|
Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate.
|
Surg Endosc
|
2012
|
0.80
|
|
47
|
Clinical analysis of high serum IgE in autoimmune pancreatitis.
|
World J Gastroenterol
|
2010
|
0.80
|
|
48
|
AA amyloid nephropathy with predominant vascular deposition in Crohn's disease.
|
Clin Nephrol
|
2013
|
0.80
|
|
49
|
Improvement of prognosis for unresectable biliary tract cancer.
|
World J Gastroenterol
|
2013
|
0.79
|
|
50
|
A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancer.
|
Chemotherapy
|
2013
|
0.79
|
|
51
|
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
|
J Gastroenterol
|
2012
|
0.77
|
|
52
|
Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction.
|
J Gastroenterol
|
2013
|
0.77
|
|
53
|
Estimation and comparison of cumulative incidences of biliary self-expandable metallic stent dysfunction accounting for competing risks.
|
Dig Endosc
|
2013
|
0.77
|
|
54
|
Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction.
|
J Gastroenterol
|
2013
|
0.76
|
|
55
|
Preservation of papillary relaxation after endoscopic papillary balloon dilation.
|
Hepatogastroenterology
|
2008
|
0.76
|